Comparative effects of cytotoxic agents on transplanted hematopoietic and antibody-producing cells.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000921:Antibody-Producing Cells / Q000187:drug effects* / Q000637:transplantation; D000961:Antilymphocyte Serum / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002330:Carmustine / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D003520:Cyclophosphamide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D007116:Immunization, Passive; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D008954:Models, Biological; D013154:Spleen / Q000166:cytology; D013997:Time Factors; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D003609:Dactinomycin; D003520:Cyclophosphamide; D015122:Mercaptopurine; D002330:Carmustine; D008727:Methotrexate